Exploring inhibition in the brain and its role in health and disease
Official title: 2025 Inhibitions in the CNS Gordon Research Conference and Gordon Research Seminar
Funded at Gordon Research Conferences · NIH-11062028 · Data updated 2026-11-12
This study is all about a conference where scientists come together to talk about how a special brain chemical called GABA helps control brain activity, with the hope of finding new ways to help kids with brain disorders.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gordon Research Conferences NIH-funded |
| Lab location | 1 site (East Greenwich, UNITED STATES) |
| Project start | February 1, 2025 |
| Project end | January 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $20,000 |
| NIH project number | 1R13NS141192-01 |
| Project ID | NIH-11062028 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include children with neurological and developmental disorders, particularly those related to inhibitory neurotransmission.
✕Less likely to help
Patients with conditions unrelated to inhibitory neurotransmission or those outside the age range of 0-11 years may not receive benefit from this research.
What this research studies
This research focuses on a conference that brings together scientists to discuss the role of inhibitory neurotransmission in the Central Nervous System, particularly how it relates to brain function and disorders. The conference will feature presentations and discussions on novel findings related to GABA, a key neurotransmitter involved in inhibition. Participants, including junior scientists, will have the opportunity to share their research and ideas, which may lead to new therapeutic approaches for treating neurological and developmental disorders in children. The event aims to foster collaboration and innovation in understanding brain function and dysfunction.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurological and developmental disorders in children.
How similar studies have gone: Previous conferences in this series have successfully advanced understanding in the field, indicating a strong potential for impactful discussions and findings.
Where this research is happening
-
Gordon Research Conferences
East Greenwich, United States Active
Researchers
- Principal investigator: Losonczy, Attila — Gordon Research Conferences
- Study coordinator: Losonczy, Attila
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.